Resonance Health Limited (ASX:RHT)

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Intersegment Elimination	-2.97M	-1.01M	-233.16K	-	-
Resonance Clinical	7.54M	4.16M	3.93M	-	-
Trialswest	4.15M	2.66M	348.81K	-	-
SaMD (Including Research & Development )	7.04M	5.27M	-	-	-
Research & Development	-	-	4.54M	-	-
Services	-	-	-	4.40M	3.83M
Total	15.75M	11.07M	8.59M	4.40M	3.83M

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017
Asia/Pacific	10.07M	2.75M	4.32M	293.89K	327.91K
North America	3.93M	2.03M	2.64M	2.78M	2.58M
EMEA	1.75M	6.30M	1.64M	1.33M	920.74K
South America	-	-	-	-	3.81K
Total	15.75M	11.07M	8.59M	4.40M	3.83M

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 9, 2026

Data Sources Report a data error